Select Language:
EnglishEspañol
Adjust Text Size:
change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Browse Clinical Trials


Join the Email List

Sign up for our email bulletin

Go

Participant Stories

“I feel like there is hope, great hope, more hope now than ever before.” –Peggy Willocks, Diagnosed 14 years

Read More

Recently Diagnosed with Parkinson's Disease?

If you have recently been diagnosed with Parkinson’s disease (PD) understanding the disease, and learning about the resources available to you, are good first steps.

Learn More

Examination of Motor and Cognitive Planning in People with Parkinson's Disease

Official Study Title: Investigations of pre-motor processing during speech production
Sponsor: NIH/National Institute of Deafness and Other Communication Disorders
Clinicaltrials.gov ID:
Study ID:

Summary

This study will examine how the brain gets ready to give a response. Two areas in particular that have been shown to be especially difficult for some people with Parkinson's disease  Parkinson's DiseaseA chronic, slowly progressive disease of the nervous system characterized by the combination of tremor, rigidity, bradykinesia and stooped posture, among other symptoms. (PD) are (1) quickly switching between movements or thoughts or (2) holding on to the "planning" of a movement or thought over time. To understand these processes, the investigator uses reaction time tasks (e.g., reaction time to say a word or press a button). Participants are asked complete one reaction time session while off of their PD medications for 15 hours. Participants also complete tests of language, memory and other higher level cognitive  CognitiveRelated to mental activities having to do with perception, memory, judgment, and reasoning. functions. The study involves three sessions that are conducted on the University of Washington campus.

Study Phase

Not Applicable
What is a study phase?

Symptoms Addressed: Study does not address symptoms

Study does not address symptoms

Time Commitment

  • Less than one month
  • 3 sessions for participants with PD; 2 sessions for control participants. (1st session = approx 2 hours, 2nd and 3rd sessions = approx 1.5 hours)

Eligibility

  • Gender(s) Accepted: Either
  • Study is enrolling non-PD participants

Inclusion Criteria

  • Native English speaker
  • Adequate hearing and vision
  • Currently taking PD medications

Exclusion Criteria

  • Neurological problems aside from PD (e.g., history of stroke, seizure disorder, head injury etc.)

Enrollment

Expected Enrollment: 70 (US)
Date Enrollment Began: Jul 01 2007
Last Updated Date: Jan 02 2008
Trial Post Date: Jan 02 2008
Website:

Primary Contacts and Locations

Washington

  • Kristie Spencer — Primary Investigator
    University of Washington
    kas@u.washington.edu
    Phone: 206-543-7980
    1417 NE 42nd Street
    Seattle, WA 98105
    USA

built@zoomedia